Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
Clinical trial NCT00691873 · COMPLETED
Trial details
- NCT number
- NCT00691873
- Sponsor
- University of Mississippi Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.